Generics in South Africa - 麻豆原创 Summary, Competitive Analysis and Forecast to 2025
Summary
Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The South African generics market had total revenues of $603.6m in 2020, representing a compound annual growth rate (CAGR) of 4.9% between 2016 and 2020.
- 麻豆原创 consumption volume increased with a CAGR of 2.6% between 2016 and 2020, to reach a total of 65.2% in 2020.
- The main factors driving market growth in South Africa are a change in patient perception and positive attitude towards the generic medicines, combined with the narrowing quality gap and broadening cost differences between branded medication and generics.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in South Africa
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Africa
- Leading company profiles reveal details of key generics market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Africa generics market with five year forecasts
Reasons to Buy
- What was the size of the South Africa generics market by value in 2020?
- What will be the size of the South Africa generics market in 2025?
- What factors are affecting the strength of competition in the South Africa generics market?
- How has the market performed over the last five years?
- What are the main segments that make up South Africa's generics market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. 麻豆原创 volume
1.4. 麻豆原创 volume forecast
1.5. Geography segmentation
1.6. 麻豆原创 rivalry
1.7. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
3.2. 麻豆原创 volume
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
5.2. 麻豆原创 volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 Company Profiles
8.1. Aspen Pharmacare Holdings Ltd
8.2. Teva Pharmaceutical Industries Limited
8.3. Adcock Ingram Holdings Ltd
8.4. Pfizer Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: South Africa generics market value: $ million, 2016-20
Table 2: South Africa generics market volume: %, 2016-20
Table 3: South Africa generics market geography segmentation: $ million, 2020
Table 4: South Africa generics market value forecast: $ million, 2020-25
Table 5: South Africa generics market volume forecast: %, 2020-25
Table 6: Aspen Pharmacare Holdings Ltd: key facts
Table 7: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 8: Aspen Pharmacare Holdings Ltd: Key Employees
Table 9: Teva Pharmaceutical Industries Limited: key facts
Table 10: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 11: Teva Pharmaceutical Industries Limited: Key Employees
Table 12: Adcock Ingram Holdings Ltd: key facts
Table 13: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 14: Adcock Ingram Holdings Ltd: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued
Table 19: South Africa size of population (million), 2016-20
Table 20: South Africa gdp (constant 2005 prices, $ billion), 2016-20
Table 21: South Africa gdp (current prices, $ billion), 2016-20
Table 22: South Africa inflation, 2016-20
Table 23: South Africa consumer price index (absolute), 2016-20
Table 24: South Africa exchange rate, 2016-20
List of Figures
List of Figures
Figure 1: South Africa generics market value: $ million, 2016-20
Figure 2: South Africa generics market volume: %, 2016-20
Figure 3: South Africa generics market geography segmentation: % share, by value, 2020
Figure 4: South Africa generics market value forecast: $ million, 2020-25
Figure 5: South Africa generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in South Africa, 2020
Figure 7: Drivers of buyer power in the generics market in South Africa, 2020
Figure 8: Drivers of supplier power in the generics market in South Africa, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in South Africa, 2020
Figure 11: Drivers of degree of rivalry in the generics market in South Africa, 2020
Aspen Pharmacare Holdings Ltd
Teva Pharmaceutical Industries Limited
Adcock Ingram Holdings Ltd
Pfizer Inc.
听
听
*If Applicable.